Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Study of Docosahexaenoic Acid (DHA) Supplementation in Patients With X-Linked Retinitis Pigmentosa

NCT00004827 is registered in ClinicalTrials.gov with Retina Foundation of the Southwest as lead sponsor.

NCT NCT00004827
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT00004827 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Study of Docosahexaenoic Acid (DHA) Supplementation in Patients With X-Linked Retinitis Pigmentosa
Lead sponsor
Retina Foundation of the Southwest
Phase
Not applicable
Overall status
Completed
Start date
March 31, 1996
Completion date
June 30, 2002
Enrollment
46
Sites
Not reported

Conditions

As the registry lists them; a condition with its own page is linked.

retinitis pigmentosa